INDV
Indivior·NASDAQ
--
--(--)
--
--(--)
INDV fundamentals
Indivior (INDV) Revenue Breakdown: Q3 2025 Business & Regional Performance
Indivior (INDV) reported total revenue of 268.00M USD in Q3 2025, with its core business segment Buprenorphine extended release contributing 75.75%. Regionally, United States remained the largest market, accounting for 85.03% of total revenue. Explore Indivior's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
Indivior (INDV) reported total revenue of 268.00M USD in Q3 2025, with its core business segment Buprenorphine extended release contributing 75.75%. Regionally, United States remained the largest market, accounting for 85.03% of total revenue. Explore Indivior's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
By Business
No Data
By Region
No Data
You can ask Aime
What factors drove the changes in Indivior's revenue and profit?What is Indivior's gross profit margin?What is Indivior's latest dividend and current dividend yield?What does Indivior do and what are its main business segments?Did Indivior beat or miss consensus estimates last quarter?What guidance did Indivior's management provide for the next earnings period?What is the revenue and EPS growth rate for Indivior year over year?What were the key takeaways from Indivior's earnings call?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
